Darwin Global Management

Latest statistics and disclosures from Darwin Global Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RVMD, INSM, BLTE, ABVX, ROIV, and represent 100.00% of Darwin Global Management's stock portfolio.
  • Added to shares of these 3 stocks: RVMD (+$1.6B), ABVX (+$15M), BLTE.
  • Reduced shares in these 3 stocks: INSM (-$1.1B), ROIV, DNTH.
  • Sold out of its position in DNTH.
  • Darwin Global Management was a net buyer of stock by $550M.
  • Darwin Global Management has $3.8B in assets under management (AUM), dropping by -0.28%.
  • Central Index Key (CIK): 0001839209

Tip: Access up to 7 years of quarterly data

Positions held by Darwin Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Darwin Global Management

Darwin Global Management holds 5 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines (RVMD) 54.5 $2.0B +380% 11M 192.62
 View chart
Insmed Com Par $.01 (INSM) 17.9 $674M -61% 6.4M 104.74
 View chart
Belite Bio Sponsored Ads (BLTE) 12.1 $457M 3.1M 148.38
 View chart
Abivax Sa Sponsored Ads (ABVX) 9.3 $348M +4% 3.6M 96.15
 View chart
Roivant Sciences SHS (ROIV) 6.2 $234M 6.7M 34.73
 View chart

Past Filings by Darwin Global Management

SEC 13F filings are viewable for Darwin Global Management going back to 2020

View all past filings